Obesity ramps up thoracic surgery costs

NewsGuard 100/100 Score

By Sarah Guy, medwireNews Reporter

Obese patients have significantly increased operating times when undergoing lobectomy for primary lung cancer, show US study results.

Every 10-unit increase in body mass index (BMI) is associated with a significant 7.2-minute increase in mean total operating room (OR) time, which could represent a major source of high healthcare costs associated with obesity in the USA, say the researchers.

The finding "must be considered on both a hospital and a national policy level," write Eric Grogan (Vanderbilt University, Nashville, Tennessee) and colleagues in the Annals of Thoracic Surgery.

The study cohort included 19,337 individuals treated with lobectomy between 2006 and 2010, whose data is stored in the Society of Thoracic Surgeons General Thoracic Surgery database.

Patients had a mean BMI of 27.3 kg/m2, where a BMI of 30.0 kg/m2 indicated obesity, and the majority of the cohort (68.4%) had a BMI under this level.

The mean total OR time was 240 minutes, and the mean length of stay in hospital was 6.9 days. A total of 1.8% of all patients died within 30 days of their surgery.

OR times rose incrementally with increasing BMI above the obesity threshold, report the researchers, such that a lobectomy in a patient with a BMI of 45 kg/m2 took approximately 15 minutes longer than one in a patient with a BMI of 25 kg/m2 .

In addition, black race, male gender, and preoperative chest radiation therapy were also significantly associated with longer OR time, increasing the procedure length by a respective 7.2, 19.2, and 16.8 minutes.

The reasons for these associations are unclear, write the authors, but imply "that there are other factors associated with race and sex that still need to be elucidated."

Grogan and co-workers found no significant association between obesity and 30-day mortality, contrary to previous research.

"If the prevalence of obesity continues to rise, a greater number of patients undergoing lobotomies for lung cancer will likely be obese," they conclude.

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
From gut to mind: Exploring prebiotics and probiotics as dual fighters against depression and obesity